col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: International Journal of Cardiology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―17 Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors Ernesto Crisafulli, Gianluigi Dorelli, Giulia Sartori, Luca Dalle Carbonare
2 [GO] 2021―Aug―31 Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) Maurizio Dondi, Elisa Milan, Gianluca Pontone, Cole B. Hirschfeld, Michelle Williams, Leslee J. Shaw, et al. (+11)
3 [GO] 2021―Aug―18 Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients Antonio Abbate, Josh Gavin, Nima Madanchi, Christin Kim, Pranav R. Shah, Katherine Klein, et al. (+3)
4 [GO] 2021―Aug―02 Troponin elevation in COVID-19 patients: An important stratification biomarker with still some open questions Alessandro Maloberti, Marco Biolcati, Cristina Giannattasio
5 [GO] 2021―Jul―31 A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era Javeria Jamal, Aiden O'Loughlin, John K. French
6 [GO] 2021―Jul―30 Genetic factors may affect the severity of COVID-19 Zhenzhen Zheng, Yuanming Zhou, Xishi Sun, Zhiqiang Wang, Chaoyu Wang, Jiangpeng Lin, et al. (+6)
7 [GO] 2021―Jul―24 Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up Piero Clavario, Vincenzo De Marzo, Roberta Lotti, Cristina Barbara, Annalisa Porcile, Carmelo Russo, et al. (+11)
8 [GO] 2021―Jul―21 Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter Felice Gragnano, Arturo Cesaro, Francesco Pelliccia, Paolo Calabrò
9 [GO] 2021―Jul―03 Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up Viviana Maestrini, Lucia Ilaria Birtolo, Marco Francone, Gioacchino Galardo, Nicola Galea, Paolo Severino, et al. (+74)
10 [GO] 2021―Jun―19 Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin Alessandro Maino, Enrico Di Stasio, Maria Chiara Grimaldi, Luigi Cappannoli, Erica Rocco, Rocco Vergallo, et al. (+5)
11 [GO] 2021―May―31 A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play Luna Cavigli, Federica Frascaro, Francesca Turchini, Nicola Mochi, Patrizio Sarto, Stefano Bianchi, et al. (+7)
12 [GO] 2021―May―15 Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19 Xue-Ting Li, Mi-Wen Zhang, Zhen-Zhou Zhang, Yu-Dan Cao, Xiao-Yan Liu, Ran Miao, et al. (+8)
13 [GO] 2021―May―08 The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19 Anum Minhas, Julie K. Shade, Sung-Min Cho, Erin D. Michos, Thomas Metkus, Nisha A. Gilotra, et al. (+3)
14 [GO] 2021―Apr―24 Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst? Martino Pepe, Giacomo Frati, Giuseppe Biondi-Zoccai, Nicola Corcione, Arturo Giordano
15 [GO] 2021―Apr―19 How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic Artur Fedorowski, David Erlinge
16 [GO] 2021―Mar―29 Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry Fabrizio D'Ascenzo, Ovidio De Filippo, Andrea Borin, Lucia Barbieri, Marianna Adamo, Nuccia Morici, et al. (+22)
17 [GO] 2021―Mar―29 Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia? C. de Roquetaillade, B.G. Chousterman, A. Mebazaa
18 [GO] 2021―Mar―23 Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy Andrea Rognoni, Fabrizio D'Ascenzo, Martina Solli, Marco G. Mennuni, Vincenzo Galiffa, Roberta Rosso, et al. (+18)
19 [GO] 2021―Mar―08 Reply to: Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure Marco Schiavone, Alessio Gasperetti, Cecilia Gobbi, Mattia Busana, Giovanni B. Forleo
20 [GO] 2021―Feb―22 Response to Zhou et al. regarding Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Alexander Tan, Daniel M. Jones, Mahmood Ahmad
21 [GO] 2021―Feb―22 Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO? Caroline Bleakley, Suveer Singh, Antonio de Marvao, Marco Morosin, Emmanouil Androulakis, Antonio Cannata, Susanna Price
22 [GO] 2021―Feb―22 Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure Ping Wang, Rong Wang, Juanjuan Tang, Yang Li, Jinjun Ma
23 [GO] 2021―Jan―30 Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2 Òscar Miró, Pere Llorens, Sònia Jiménez, Pascual Piñera, Guillermo Burillo, Alfonso Martín, et al. (+112)
24 [GO] 2021―Jan―29 Reply to Letter to the Editor - in response to: Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19). Wenqian Zhou, Yushi Wang, Yang Zheng
25 [GO] 2021―Jan―29 Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study Baptiste Maille, Marie Wilkin, Matthieu Millon, Noémie Rességuier, Frédéric Franceschi, Linda Koutbi-Franceschi, et al. (+8)
26 [GO] 2021―Jan―28 RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO? Vasiliki Tsolaki, George E. Zakynthinos
27 [GO] 2021―Jan―27 Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? Juan Tamargo
28 [GO] 2020―Dec―30 Interplay between COVID-19, pollution, and weather features on changes in the incidence of acute coronary syndromes in early 2020 Francesco Versaci, Achille Gaspardone, Alessandro Danesi, Fabio Ferranti, Massimo Mancone, Enrica Mariano, et al. (+16)
29 [GO] 2020―Dec―11 Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study Gentian Denas, Nicola Gennaro, Eliana Ferroni, Ugo Fedeli, Giulia Lorenzoni, Dario Gregori, et al. (+2)
30 [GO] 2020―Dec―08 Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China Wen-Xiu Leng, Jin-Gang Yang, Xiang-Dong Li, Wen-Yang Jiang, Li-Jian Gao, Yuan Wu, et al. (+5)
31 [GO] 2020―Dec―02 Challenges in activation of remote monitoring in patients with cardiac rhythm devices during the coronavirus (COVID-19) pandemic Angelo Auricchio, Giulio Conte, Andrea Demarchi, Enrico Baldi, Tardu Ozkartal, Francois Regoli, Tiziano Moccetti
32 [GO] 2020―Nov―27 Cardiovascular screening of athletes during the COVID-19 pandemic: The (ir)relevance of elevated cardiac troponins Caroline M. Van De Heyning, Hielko Miljoen
33 [GO] 2020―Nov―25 Letter to the Editor - in response to: Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Alexander Tan, Daniel M. Jones, Mahmood Ahmad
34 [GO] 2020―Nov―25 Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link” Islam Y. Elgendy, Carl J. Pepine
35 [GO] 2020―Nov―23 Right ventricular dysfunction in critically ill COVID-19 ARDS Caroline Bleakley, Suveer Singh, Benjamin Garfield, Marco Morosin, Elena Surkova, Ms Sundhiya Mandalia, et al. (+11)
36 [GO] 2020―Nov―23 Interpretation of elevated high-sensitivity cardiac troponin I in elite soccer players previously infected by severe acute respiratory syndrome coronavirus 2 Giuseppe Mascia, Fabio Pescetelli, Amedeo Baldari, Piero Gatto, Sara Seitun, Paolo Sartori, et al. (+4)
37 [GO] 2020―Nov―10 From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 R. Vinci, D. Pedicino, F. Andreotti, G. Russo, A. D'Aiello, R. De Cristofaro, et al. (+2)
38 [GO] 2020―Oct―26 Myocardial injury in COVID-19: When observations become reality Giacomo Veronese, Dario Winterton, Enrico Ammirati
39 [GO] 2020―Oct―22 Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Wenqian Zhou, Ling Song, Xiang Wang, Zheng Xu, Shudong Wang, Jiqun Wang, et al. (+3)
40 [GO] 2020―Oct―20 COVID-19 and arterial thrombosis: A potentially fatal combination Francesco Moroni, Luca Baldetti
41 [GO] 2020―Oct―16 Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem Fresse Audrey, Viard Delphine, Romani Serena, Gerard Alexandre, Lepelley Marion, Rocher Fanny, et al. (+2)
42 [GO] 2020―Oct―08 Extent of lung involvement over severity of cardiac disease for the prediction of adverse outcome in COVID-19 patients with cardiovascular disease Daniele Andreini, Edoardo Conte, Saima Mushtaq, Carlo Gigante, Maria Elisabetta Mancini, Andrea Annoni, et al. (+6)
43 [GO] 2020―Sep―28 Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- Cosmo Godino, Andrea Scotti, Norma Maugeri, Nicasio Mancini, Evgeny Fominskiy, Alberto Margonato, Giovanni Landoni
44 [GO] 2020―Sep―25 The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy Antonio Desai, Giuseppe Voza, Silvia Paiardi, Francesca Ilaria Teofilo, Giuseppe Caltagirone, Marta Ripoll Pons, et al. (+13)
45 [GO] 2020―Sep―23 Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia Chongtu YangMD, Fen LiuMD, Wei LiuMD, Guijuan CaoMD, Jiacheng LiuMD, Songjiang HuangMD, et al. (+4)
46 [GO] 2020―Sep―19 Assessing QT interval in COVID-19 patients: Safety of Hydroxychloroquine-azithromycin combination regimen Andrea Bernardini, Giuseppe Ciconte, Gabriele Negro, Roberto Rondine, Valerio Mecarocci, Tommaso Viva, et al. (+10)
47 [GO] 2020―Sep―10 Unusual arterial thrombotic events in Covid-19 patients C. de Roquetaillade, B.G. Chousterman, D. Tomasoni, M. Zeitouni, E. Houdart, A. Guedon, et al. (+6)
48 [GO] 2020―Sep―10 Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link Jef Van den Eynde, Keir R.G. McCutcheon
49 [GO] 2020―Sep―08 Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience Marco Schiavone, Alessio Gasperetti, Massimo Mancone, Antonio Curnis, Giosuè Mascioli, Gianfranco Mitacchione, et al. (+6)
50 [GO] 2020―Sep―01 Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb. Amélie Cransac-Miet, Marianne Zeller, Frédéric Chagué, Agnès Soudry Faure, Florence Bichat, Nicolas Danchin, et al. (+2)
51 [GO] 2020―Aug―25 Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE) Giorgio Quadri, Andrea Rognoni, Enrico Cerrato, Giorgio Baralis, Giacomo Boccuzzi, Elvis Brsic, et al. (+19)
52 [GO] 2020―Aug―13 Women's perspective on the COVID-19 pandemic: Walking into a post-peak phase Jolanda Sabatino, Sara Moscatelli, Yasmin Rustamova, Irina Kotlar, Martina Avesani, Margarita Brida, et al. (+8)
53 [GO] 2020―Jul―30 Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome? Massimo Volpe, Allegra Battistoni
54 [GO] 2020―Jul―25 HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease Yunzhao Li, Di Liu, Hui Wu
55 [GO] 2020―Jul―13 The cardiovascular burden of congenital heart disease - not only in times of COVID-19 Jan Müller, Leon Brudy, Michael Meyer, Peter Ewert, Renate Oberhoffer
56 [GO] 2020―Jul―04 Acute pulmonary embolism in COVID-19 disease Serdar Kalemci, Aydın Sarıhan, Arife Zeybek, Ahmet Bülent Kargi
57 [GO] 2020―Jun―28 COVID-19 trials in Italy: A call for simplicity, top standards and global pooling Aldo P. Maggioni, Felicita Andreotti, Cristina Gervasoni, Giuseppe Di Pasquale
58 [GO] 2020―Jun―19 Triage and management of the ACHD patient with COVID-19: A single center approach Lauren T. Lastinger, Curt J. Daniels, Marc Lee, Aarthi Sabanayagam, Elisa A. Bradley
59 [GO] 2020―Jun―16 COVID-19 myocardial injury: We have much more to discover Dimitrios A. Vrachatis, Sotiria G. Giotaki, Georgios Giannopoulos
60 [GO] 2020―Jun―16 Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence Bo Hu, Qing Deng, Qing Zhou
61 [GO] 2020―Jun―03 COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? Lorenzo Loffredo, Francesco Violi
62 [GO] 2020―May―29 Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research Maria Frigerio
63 [GO] 2020―May―29 Response to the letter, “The cardiovascular burden of congenital heart disease - not only in times of COVID-19 Weiyi Tan, Jamil Aboulhosn
64 [GO] 2020―May―26 Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients Pompilio Faggiano, Andrea Bonelli, Sara Paris, Giuseppe Milesi, Stefano Bisegna, Nicola Bernardi, et al. (+3)
65 [GO] 2020―May―19 Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin Alberto Cipriani, Alessandro Zorzi, Davide Ceccato, Federico Capone, Matteo Parolin, Filippo Donato, et al. (+10)
66 [GO] 2020―May―11 Why are women better protected from COVID-19: Clues for men? Sex and COVID-19 Islam Y. Elgendy, Carl J. Pepine
67 [GO] 2020―Apr―25 Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak Marco Ferlini, Aida Andreassi, Stefano Carugo, Claudio Cuccia, Beatrice Bianchini, Battistina Castiglioni, et al. (+12)
68 [GO] 2020―Apr―11 More clinical warning indicators should be explored for monitoring COVID-19 patients' condition Chaojun Yang, Jian Yang, Jing Zhang, Jun Yang
69 [GO] 2020―Apr―08 Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China Qing Deng, Bo Hu, Yao Zhang, Hao Wang, Xiaoyang Zhou, Wei Hu, et al. (+4)
70 [GO] 2020―Apr―06 SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients Enrico Ammirati, Dao Wen Wang
71 [GO] 2020―Apr―06 An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients Jing-Zhang Wang, Rui-Ying Zhang, Jing Bai
72 [GO] 2020―Apr―04 The globe on the spotlight: Coronavirus disease 2019 (Covid-19) Margarita Brida, Massimo Chessa, Hong Gu, Michael A. Gatzoulis
73 [GO] 2020―Mar―31 Commentary: What is the relationship between Covid-19 and cardiovascular disease? R. Ferrari, G. Di Pasquale, C. Rapezzi
74 [GO] 2020―Mar―28 The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease Weiyi Tan, Jamil Aboulhosn


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.004 sec